OraSure Technologies to Present at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum
09 Novembre 2016 - 12:00PM
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care
diagnostic tests and specimen collection devices, today announced
that Douglas A. Michels, President and CEO, will speak to the
investment community at the 10th Annual Canaccord Genuity Medical
Technology & Diagnostics Forum in New York. The
conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on November 17, 2016, at
approximately 9:00 AM Eastern Time (6:00 AM Pacific Time).
Interested investors can access the live webcast of the
presentation by going to OraSure Technologies’ web site,
www.orasure.com, and clicking on the Investor Info link. A
replay of the webcast will be available on OraSure Technologies’
web site for seven days. Alternatively, you can access the
live webcast of the presentation via the following link:
http://wsw.com/webcast/canaccord24/osur.
About OraSure
TechnologiesOraSure Technologies is a leader in
the development, manufacture and distribution of point of care
diagnostic and collection devices and other technologies designed
to detect or diagnose critical medical conditions. Its
first-to-market, innovative products include rapid tests for the
detection of antibodies to HIV and HCV on the OraQuick® platform,
oral fluid sample collection, stabilization and preparation
products for molecular diagnostic applications, and oral fluid
laboratory tests for detecting various drugs of abuse. OraSure's
portfolio of products is sold globally to various clinical
laboratories, hospitals, clinics, community-based organizations and
other public health organizations, research and academic
institutions, distributors, government agencies, physicians'
offices, commercial and industrial entities and consumers. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health.
For more information on OraSure Technologies, please visit
www.orasure.com.
Company contact:
Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024